Showing 151-160 of 9443 results for "".
- Fractional CO₂ Laser-Assisted Methotrexate Rivals 5-FU in Stable Vitiligohttps://practicaldermatology.com/news/fractional-co-laser-assisted-methotrexate-rivals-5-fu-in-stable-vitiligo/2487990/Topical methotrexate (MTX) delivered through fractional CO₂ laser (FCL) demonstrated efficacy and safety comparable to laser-assisted 5-fluorouracil (5-FU) for stable, nonsegmental vitiligo, according to a study published in Derm
- Meta-Analysis: Comparable Overall Outcomes With Lasers and Chemical Peels for Skin Rejuvenationhttps://practicaldermatology.com/news/meta-analysis-vcomparable-overall-outcomes-with-lasers-and-chemical-peels-for-skin-rejuvenation/2487992/A systematic review and meta-analysis published in Plastic and Reconstructive Surgery found that laser resurfacing and chemical peeling provide comparable overall efficacy for skin rejuvenation, although each modality demon
- Secondary Liquid Rhinoplasty Achieves 90%+ Patient Satisfaction: Studyhttps://practicaldermatology.com/news/secondary-liquid-rhinoplasty-achieves-90-patient-satisfaction-study/2487989/Secondary liquid rhinoplasty using hyaluronic acid dermal fillers may offer a safe and effective option for correcting postsurgical nasal contour irregularities, according to a large retrospective study published in the Aesthetic
- Analysis: Antiepileptic Drugs Linked to Nearly One-Quarter of Global SJS/TEN Caseshttps://practicaldermatology.com/news/antiepileptic-drugs-linked-to-nearly-one-quarter-of-global-sjsten-cases-meta-analysis-finds/2487988/Antiepileptic drugs (AEDs) account for nearly one-quarter of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) cases reported worldwide, according to a systematic review and meta-analysis in JAMA Dermatology
- Analysis: Topical Corticosteroids Effective for Select Patients With DRESS Syndromehttps://practicaldermatology.com/news/analysis-data-support-topical-corticosteroids-for-select-patients-with-dress-syndrome/2487960/Topical corticosteroids may offer comparable short-term outcomes to systemic corticosteroids for selected hospitalized patients with drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, according to a multicenter retrospective cohort study publi
- EV-Related Skin Toxic Effects Associated With Improved Survival in Urothelial Cancer: Analysishttps://practicaldermatology.com/news/ev-related-skin-toxic-effects-associated-with-improved-survival-in-urothelial-cancer/2487950/Cutaneous adverse events (cAEs) that develop during treatment with enfortumab vedotin (EV) may serve as a favorable prognostic marker in patients with locally advanced or metastatic urothelial carcinoma, according to a new study published online in
- GLP-1 Receptor Agonists Linked to Reduced Psoriasis Treatment Escalation in Type 2 Diabetics: Analysishttps://practicaldermatology.com/news/glp-1-receptor-agonists-linked-to-reduced-psoriasis-treatment-escalation-in-type-2-diabetics-analysis/2487939/Adults with psoriasis and type 2 diabetes mellitus (T2DM) treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were less likely to require escalation of psoriasis therapy than patients receiving most other antihyperglycemic medications, according to
- Study: Intentional Outdoor Tanning Common Among US Adults, Especially Young Womenhttps://practicaldermatology.com/news/intentional-outdoor-tanning-remains-common-among-us-adults-especially-young-women/2487924/Intentional outdoor tanning remains a common behavior among US adults, particularly younger women, according to a large cross-sectional analysis of nationally representative survey data published online in JAMA Dermatology.<
- Sanofi Halts Amlitelimab Development in Atopic Dermatitishttps://practicaldermatology.com/news/sanofi-halts-amlitelimab-development-in-atopic-dermatitis/2487921/Sanofi has announced it will discontinue the clinical development of amlitelimab for moderate-to-severe atopic dermatitis (AD), ending plans to submit the investigational therapy for global regulatory review after determining it would not provide a meaningful adva
- Tapinarof Demonstrates Consistent Efficacy Across Pediatric and Adult Patients With Atopic Dermatitishttps://practicaldermatology.com/news/tapinarof-demonstrates-consistent-efficacy-across-pediatric-and-adult-patients-with-atopic-dermatitis/2487900/Organon will present new data from a post hoc pooled analysis of the Phase 3 ADORING 1 and ADORING 2 trials at the 2026 Society for Pediatric Dermatology (SPD) Annual Meeting in Minneapolis, Minnesota, showing that tapinarof (VTAMA) cream 1% produced early and consistent improvements in patients